Zealand Pharma A/S
They are a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. Currently, their shares are traded on Nasdaq Copenhagen A/S, or Nasdaq Copenhagen, under the symbol ZEAL. The closing price of our shares on Nasdaq Copenhagen on August 1, 2017 was DKK 121.50 per share, which equals a price of $19.30 per ADS based on the DKK/U.S. dollar exchange rate as of August 1, 2017.
Last Closing Price
Morgan Stanley, Goldman Sachs & Co.
To view the prospectus for Zealand Pharma A/S, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277